Mineralys Therapeutics, Inc.'s total assets for Q4 2024 were $205.90M, a decrease of -23.24% from the previous quarter. MLYS total liabilities were $14.65M for the fiscal quarter, a -53.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.